RENEW · 215ON201
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety, tolerability and pharmacokinetics of BIIB033 in participants with a first episode of acute optic neuritis. EudraCT: 2011-006291-39.
Sponsor: BIOGEN
Phase: II
Area: Neuroimmunology